去心房顫動市場規模、佔有率、成長分析（按類型、患者類型、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，去心房顫動市場規模將達到 163.2 億美元，到 2025 年將達到 176.4 億美元，到 2033 年將達到 329 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.1%。

去心房顫動市場正經歷顯著成長，這主要得益於技術進步、心臟麻痹率上升以及公眾意識提升的提高。政府和醫療保健機構的措施在促進去心房顫動的廣泛使用和普及方面也發揮關鍵作用。家用個人體外心臟去心房顫動（AED）等創新產品正在拓展市場機會。儘管目前已採取預防措施，但心臟麻痹仍然是心血管死亡的主要原因之一，這表明植入式心臟整流去顫器（ICD）和體外去心房顫動器（AED）的需求量很大。尤其是在發展中國家，公眾意識的不斷提高，以及旨在促進心臟健康和改進培訓計畫的區域性舉措，進一步推動了市場擴張。主要企業正在提供多樣化的產品系列以滿足不同環境的需求，從而鞏固其市場地位並推動收入成長。

去心房顫動市場促進因素

全球去心房顫動市場的主要促進因素之一是心血管疾病的日益流行，心血管疾病是全球首要死因。隨著人口老化和久坐生活方式的盛行，心律不整和心臟麻痹等心臟相關疾病的發生率顯著上升。這一日益嚴重的健康問題促使人們更加關注並需要先進的醫療干預措施，包括在醫院、緊急應變系統和公共場所部署去心房顫動。此外，技術的不斷進步，例如攜帶式和方便用戶使用型設備的開發，提高了緊急情況下除顫器的可及性和有效性，進一步推動了市場擴張。

去心房顫動市場的限制

全球去心房顫動市場的主要限制因素之一是先進去心房顫動設備及其相關培訓項目的高成本。由於預算限制，許多醫療機構，尤其是在中低收入地區，可能難以負擔先進去心房顫動的投資。此外，醫護人員需要持續接受訓練才能有效使用這些設備，這進一步加重了經濟負擔，並限制了這項關鍵救生技術的普及。這種經濟障礙可能會阻礙去心房顫動的廣泛應用，尤其是在醫療資源匱乏的地區，最終影響嚴重心臟疾病患者的治療效果。

去心房顫動市場趨勢

去心房顫動市場正呈現顯著的成長趨勢，這主要得益於技術的快速進步，這些進步提升了設備的效能和使用者體驗。人工智慧演算法等創新技術正被整合到除顫器中，以提高心率檢測的準確性，從而實現更快、更有效的治療。此外，無線連接正逐漸成為標準配置，方便遠端監控和資料無縫傳輸至醫療服務提供者。操作更直覺的改良型使用者介面也正在湧現，使這些救生設備更容易被一般民眾和醫療專業人員所使用。這些進步的共同作用有望改善患者的治療效果，並推動醫療保健行業的市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 案例研究
• 專利分析

全球去心房顫動市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 植入式心臟整流去顫器
  • 經靜脈植入式心臟整流去顫器
  • 植入式植入式去心房顫動
• 體外去心房顫動
  • 手動和半自動體外去心房顫動
  • 全自動體外心臟去心房顫動
  • 穿戴式去心房顫動

全球去心房顫動市場規模（依病患類型分類）及複合年成長率（2026-2033 年）

• 成人版
• 兒童

全球去心房顫動市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院、診所和心臟中心
• 院前醫療環境
• 公共准入市場
• 居家醫療環境
• 替代醫療設施
• 其他最終用戶

全球去心房顫動市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Koninklijke Philips NV（Netherlands）
• ZOLL Medical Corporation（Asahi Kasei）（USA/Japan）
• Nihon Kohden Corporation（Japan）
• Stryker（USA）
• BIOTRONIK SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Schiller AG（Switzerland）
• Mindray Medical International Ltd.（China）
• Defibtech LLC（USA）
• LivaNova PLC（UK）
• Cardiac Science Corporation（USA）
• Bexen Cardio（Spain）
• Physio-Control Inc.（USA）
• CU Medical Systems Co., Ltd.（South Korea）
• Metrax GmbH（Germany）
• BPL Medical Technologies（India）
• Avive Solutions Inc.（USA）

結論與建議

Defibrillator Market size was valued at USD 16.32 Billion in 2024 and is poised to grow from USD 17.64 Billion in 2025 to USD 32.9 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The defibrillator market is experiencing significant growth driven by advancements in technology, rising occurrences of sudden cardiac arrest, and heightened public awareness. Government and healthcare initiatives are also playing a vital role in promoting defibrillator accessibility and use. Innovations such as personal AEDs, which allow for home use, are expanding market opportunities. Despite current preventive measures, sudden cardiac arrest remains a leading cause of cardiovascular mortality, underscoring the demand for both implantable cardioverter defibrillators (ICDs) and external defibrillators. Increasing awareness, especially in developing markets, further propels market expansion, supported by local initiatives aimed at enhancing cardiac health and training programs. Leading companies demonstrate diverse product offerings to cater to various settings, reinforcing their market presence and driving revenue growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Defibrillator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Defibrillator Market Segments Analysis

Global Defibrillator Market is segmented by Type, Patients type, End Users and region. Based on Type, the market is segmented into Implantable cardioverter defibrillators and External defibrillators. Based on Patients type, the market is segmented into Adult and Pediatrics. Based on End Users, the market is segmented into Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Defibrillator Market

One of the key market drivers for the global defibrillator market is the increasing prevalence of cardiovascular diseases, which are a leading cause of mortality worldwide. As the population ages and lifestyles become more sedentary, the incidence of heart-related conditions such as arrhythmias and sudden cardiac arrest rises significantly. This growing health concern has led to heightened awareness and demand for advanced medical interventions, including the deployment of defibrillators in hospitals, emergency response systems, and public spaces. Moreover, ongoing advancements in technology, such as the development of portable and user-friendly devices, further bolster market expansion by enhancing accessibility and effectiveness in emergency situations.

Restraints in the Defibrillator Market

One key market restraint for the global defibrillator market is the high cost associated with advanced defibrillation devices and related training programs. Many healthcare facilities, particularly in low- to middle-income regions, may find it economically challenging to invest in sophisticated defibrillators due to budget constraints. Additionally, the requirement for ongoing training for medical personnel to effectively use these devices further exacerbates financial burdens, limiting access to essential life-saving technology. This financial barrier can hinder the widespread adoption of defibrillators, particularly in underserved areas, ultimately impacting patient outcomes in critical cardiac situations.

Market Trends of the Defibrillator Market

The defibrillator market is experiencing a significant upward trend fueled by rapid technological advancements that enhance device performance and user experience. Innovations such as artificial intelligence algorithms are being integrated to improve the accuracy of cardiac rhythm detection, enabling faster and more effective interventions. Additionally, wireless connectivity is becoming a standard feature, facilitating remote monitoring and seamless data transmission to healthcare providers. Enhanced user interfaces, designed for intuitive operation, are also emerging, making these life-saving devices more accessible to laypersons and healthcare professionals alike. Collectively, these advancements are poised to improve patient outcomes and drive market growth in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Patent Analysis

Global Defibrillator Market Size by Type & CAGR (2026-2033)

• Market Overview
• Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
• External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

Global Defibrillator Market Size by Patients type & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatrics

Global Defibrillator Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals, Clinics and Cardiac centres
• Pre-hospital care settings
• Public access markets
• Home care settings
• Alternate care facilities
• Other end users

Global Defibrillator Market Size & CAGR (2026-2033)

• North America (Type, Patients type, End Users)
  • US
  • Canada
• Europe (Type, Patients type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Patients type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Patients type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patients type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZOLL Medical Corporation (Asahi Kasei) (USA/Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Defibtech LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bexen Cardio (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Physio-Control Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CU Medical Systems Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avive Solutions Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations